NCT04154852View on ClinicalTrials.gov

ADalimumab in Persistent Early Oligoarthrits Study (ADEOS)

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 16, 2017

Study Completion Date

January 16, 2017

Conditions
Oligoarthritis
Interventions
DRUG

Adalimumab

DRUG

Methotrexate

DRUG

Placebo

Placebo to replace adalimumab

DRUG

Folic Acid

Trial Locations (1)

LS7 4SA

Leeds Teaching Hospitals NHS Trust, Leeds

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Leeds

OTHER

NCT04154852 - ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) | Biotech Hunter | Biotech Hunter